Work

One-carbon metabolism: An aging-cancer crossroad for the gerosuppressant metformin

Year: 2013
Type: article
Abstract: The gerosuppressant metformin operates as an efficient inhibitor of the mTOR/S6K1 gerogenic pathway due to its ability to ultimately activate the energy-sensor AMPK. If an aging-related decline in the AMPK sensitivity to cellular stress is a crucial event for mTOR-driven aging and aging-related diseases, including cancer, unraveling new proximal causes through which AMPK activation endows its gerosuppressive effects may offer not only a better understanding of metformin function but also the likely possibility of repositioning our existing gerosuppressant drugs. Here we provide our perspective on recent findings suggesting that de novo biosynthesis of purine nucleotides, which is based on the metabolism of one-carbon compounds, is a new target for metformin's actions at the crossroads of aging and cancer.
Source: Aging
Language: English
Open Access status: hybrid
OpenAlex ID: W1527555853
FWCI: 1.21
Cites: 50
Cited by: 22
Related to: 10